New biotech venture fund capitalized at $300 million

Pivotal bioVenture Partners2Pivotal bioVenture Partners closed its first fund last week, securing $300 million to invest in biotech start-ups. Click here to learn more about the new fund.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.